SANA

Sana Biotechnology, Inc.

A developer of engineered cell therapies, Sana Biotechnology works to repair or replace damaged cells in the body using its "hypoimmune" technology, which masks cells so a patient's immune system won't reject them. Founded in 2018 by former leaders of the CAR T-cell pioneer Juno Therapeutics, the company takes its name from the Latin word "sana," meaning healthy or sound. Its lead programs are off-the-shelf CAR T-cell therapies in development for autoimmune diseases like lupus.

CUSIP: 799566104HealthcareUS1 holder

Ownership Activity Financials Filings

SANA

SANA

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

Other Events

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Other Events

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements